Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-13 Purchase |
2023-03-13 4:06 pm |
Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer |
5,500 | $29.15 | $160,324 | 255,500 (Direct) |
View |
| 2023-03-09 Sale |
2023-03-10 4:05 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
29,971 | $29.07 | $871,257 | 0 (Direct) |
View |
| 2023-02-02 Sale(A) |
2023-02-07 6:35 pm |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
50,000 | $36.8 | $1,840,000 | 720,110 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-03 6:12 pm |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
50,000 | $36.8 | $1,840,000 | 430,905 (Direct) |
View |
| 2023-01-23 Sale |
2023-01-25 6:04 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
6,843 | $35.66 | $244,021 | 59,753 (Direct) |
View |
| 2023-01-13 Sale |
2023-01-18 5:58 pm |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
29,000 | $37.18 | $1,078,261 | 558,853 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 7:09 pm |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
60,000 | $34.82 | $2,089,472 | 639,377 (Direct) |
View |
| 2022-12-20 Sale |
2022-12-22 4:42 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,926 | $29.15 | $493,398 | 105,768 (Direct) |
View |
| 2022-12-15 Sale |
2022-12-19 7:22 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,597 | $28.37 | $45,311 | 124,591 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-14 8:56 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,256 | $28.12 | $457,077 | 142,144 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-16 6:45 pm |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
8,125 | $22.05 | $179,156 | 21,875 (Direct) |
View |
| 2022-08-17 Purchase |
2022-08-19 4:32 pm |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. See Remarks 10% Owner |
425,531 | $23.5 | $9,999,979 | 1,369,623 (Indirect) |
View |
| 2022-06-01 Sale |
2022-06-02 5:29 pm |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
30,000 | $12.2 | $366,000 | 480,905 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-04 5:23 pm |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
30,000 | $13.04 | $391,200 | 510,905 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 6:09 pm |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
30,000 | $18.92 | $567,636 | 540,905 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 4:48 pm |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
30,000 | $17.65 | $529,491 | 570,905 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 6:11 pm |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
30,000 | $19.09 | $572,818 | 880,905 (Direct) |
View |
| 2021-09-23 Purchase |
2021-09-28 7:46 pm |
Viridian Therapeutics Inc. | VRDN | Frazier Life Sciences Public Fund L.P. FHMLSP L.P. FHMLSP L.L.C. 10% Owner |
200,000 | $11 | $2,200,000 | 1,505,200 (Direct) |
View |
| 2021-09-21 Purchase |
2021-09-23 09:30 am |
Viridian Therapeutics Inc. | VRDN | Fairmount Funds Management LLC Fairmount Healthcare Fund GP LLC Fairmount Healthcare Fund II GP LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director 10% Owner |
909,000 | $11 | $9,999,000 | 1,077,283 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-08 Option Award |
2023-02-10 4:54 pm |
N/A 2033-02-08 |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
108,000 | $0 | 108,000 (Direct) |
View |
| 2023-02-08 Option Award |
2023-02-10 4:51 pm |
N/A 2033-02-08 |
Viridian Therapeutics Inc. | VRDN | Melvin Carrie COO |
54,000 | $0 | 54,000 (Direct) |
View |
| 2023-02-08 Option Award |
2023-02-10 4:49 pm |
N/A 2033-02-08 |
Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO |
108,000 | $0 | 108,000 (Direct) |
View |
| 2023-02-08 Option Award |
2023-02-10 4:47 pm |
N/A 2033-02-08 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
108,000 | $0 | 108,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 6:55 pm |
N/A 2033-02-06 |
Viridian Therapeutics Inc. | VRDN | Myers Scott Dunseth Chief Executive Officer |
1,250,000 | $0 | 1,250,000 (Direct) |
View |
| 2023-02-02 Exercise(A) |
2023-02-07 6:35 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
50,000 | $0.15 | 720,110 (Direct) |
View |
| 2023-02-02 Exercise(A) |
2023-02-07 6:35 pm |
N/A 2030-09-23 |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
50,000 | $0 | 720,110 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-25 6:04 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
4,971 | $23.03 | 59,753 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-25 6:04 pm |
N/A 2031-01-18 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
6,843 | $0 | 59,753 (Direct) |
View |
| 2023-01-23 Exercise |
2023-01-25 6:04 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,872 | $14 | 59,753 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-18 5:58 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
29,000 | $23.03 | 558,853 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-18 5:58 pm |
N/A 2031-01-17 |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
29,000 | $0 | 558,853 (Direct) |
View |
| 2023-01-09 Exercise |
2023-01-11 7:09 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
60,000 | $23.03 | 639,377 (Direct) |
View |
| 2023-01-09 Exercise |
2023-01-11 7:09 pm |
N/A 2031-01-17 |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
60,000 | $0 | 639,377 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-22 4:42 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,926 | $23.03 | 105,768 (Direct) |
View |
| 2022-12-20 Exercise |
2022-12-22 4:42 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,926 | $0 | 105,768 (Direct) |
View |
| 2022-12-15 Exercise |
2022-12-19 7:22 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,597 | $23.03 | 124,591 (Direct) |
View |
| 2022-12-15 Exercise |
2022-12-19 7:22 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
1,597 | $0 | 124,591 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 8:56 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,256 | $23.03 | 142,144 (Direct) |
View |
| 2022-12-12 Exercise |
2022-12-14 8:56 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
16,256 | $0 | 142,144 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-16 6:45 pm |
N/A 2031-09-22 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
8,125 | $0 | 21,875 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-16 6:45 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
8,125 | $14 | 21,875 (Direct) |
View |
Ownership |
2022-06-24 5:23 pm |
N/A 2032-06-21 |
Viridian Therapeutics Inc. | VRDN | Melvin Carrie COO |
0 | $0 | 210,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 07:30 am |
N/A 2032-06-08 |
Viridian Therapeutics Inc. | VRDN | Moses Jennifer K. Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 07:30 am |
N/A 2032-06-08 |
Viridian Therapeutics Inc. | VRDN | Kiselak Tomas Director |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2022-06-08 Option Award |
2022-06-10 07:30 am |
N/A 2032-06-08 |
Viridian Therapeutics Inc. | VRDN | Harwin Peter Evan Director |
12,500 | $0 | 12,500 (Indirect) |
View |
| 2022-06-08 Option Award |
2022-06-10 07:30 am |
N/A 2032-06-08 |
Viridian Therapeutics Inc. | VRDN | Morris Arlene Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 6:15 pm |
N/A 2032-02-02 |
Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 6:13 pm |
N/A 2032-02-02 |
Viridian Therapeutics Inc. | VRDN | Katz Barrett Chief Medical Officer |
110,000 | $0 | 110,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 6:12 pm |
N/A 2032-02-02 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-03 6:11 pm |
N/A 2032-02-02 |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan Chief Executive Officer |
280,000 | $0 | 880,905 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-03 4:16 pm |
N/A 2031-12-31 |
Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO |
121,371 | $0 | 121,371 (Direct) |
View |
| 2021-12-08 Conversion |
2021-12-10 6:08 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Violin Jonathan See Remarks |
636,977 | $0 | 630,905 (Direct) |
View |
Ownership |
2021-10-04 6:38 pm |
N/A 2031-01-18 |
Viridian Therapeutics Inc. | VRDN | Meisner Lara General Counsel and Secretary |
0 | $0 | 109,500 (Direct) |
View |
Ownership |
2021-08-26 1:08 pm |
N/A N/A |
Viridian Therapeutics Inc. | VRDN | Frazier Life Sciences Public Fund L.P. FHMLSP L.L.C. FHMLSP L.P. 10% Owner |
0 | $0 | 1,305,200 (Direct) |
View |
| 2021-07-26 Option Award |
2021-07-27 5:02 pm |
N/A 2031-07-26 |
Viridian Therapeutics Inc. | VRDN | Humer Kristian CFO and CBO |
360,000 | $0 | 360,000 (Direct) |
View |